Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Hepatocarcinogenesis by HCV infection]

A Naganuma¹, A Nozaki, N Kato

¹Department of Molecular Biology, Okayama University Graduate School of Medicine and Dentistry.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|January 5, 2002

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-world evidence of chemotherapy effects in advanced pancreatic ductal adenocarcinoma: prognostic significance of <i>TP53</i> status in gemcitabine plus nab-paclitaxel therapy.

ESMO gastrointestinal oncology·2026

Same author

Prognosis and incidence of immunological and oncological complications after direct-acting antiviral therapy for chronic hepatitis C.

Acta gastro-enterologica Belgica·2022

Same author

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022

Same author

Catalytic activity of Co-nanocrystal-doped tungsten carbide arising from an internal magnetic field.

RSC advances·2022

Same author

Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study.

Acta gastro-enterologica Belgica·2021

Same author

A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatment.

Acta gastro-enterologica Belgica·2021